GENSIGHT BIOLOGICS S.A. — Form D

GENSIGHT BIOLOGICS S.A. of Paris, I0, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-08. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2015-07-08
Form: D
Accession: 0001209191-15-060045
Industry: Biotechnology
Exemptions: 06b
Total offering: $25.0M
Amount sold: $25.0M
Investors: 15
Date of first sale: 2015-07-07
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-243245

Issuer

Name: GENSIGHT BIOLOGICS S.A.
CIK: 0001641634
Entity type: Corporation
Jurisdiction: FRANCE
Incorporated: 2012
Address: 74 rue du Faubourg Saint-Antoine, Paris, I0, 75012
Phone: 01133176217220

Officers, directors & promoters (11)

Name	Role	Location
Bernard Gilly	Director	Paris, I0
Peter Goodfellow	Director	Paris, I0
Florent Gros	Director	Menlo Park, CA
GENGHIS LLOYD-HARRIS	Director	LONDON, X0
Guido Magni	Director	Watertown, MA
Michael Stephen Wyzga	Director	Paris, I0
Jean-Philippe Combal	Executive Officer	Paris, I0
Thomas Gidoin	Executive Officer	Paris, I0
Bernard Gilly	Executive Officer	Paris, I0
Didier Pruneau	Executive Officer	Paris, I0
Nitza Thomasson	Executive Officer	Paris, I0

More